Lawson researchers receive $4.4 million to study personalized medicine at LHSC
LONDON, ON – Personalized medicine is the analysis of a patient’s DNA to predict how they will respond to medications. Led by Dr. Richard Kim, scientist at Lawson Health Research Institute (Lawson) and clinical pharmacologist at London Health Sciences Centre (LHSC), researchers at Lawson have...